The latter pattern of peripheral KMO deficiency, i.e., elevation of both KYN and KYNA without elevation of ANA, was described in type 2 diabetes [34] and might underline increased predisposition of SP to MetS. This evidence concerns the gene KMO and metabolic syndrome.